Francois-Xavier Frapaise

2PUBLICATIONS
0CO-AUTHORS
Nanotoxicology, health and safetyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 18, 2018
Author's Reply to Webster and Woollett: "The End of Phase 3 Clinical Trials in Biosimilars Development?"

Francois-Xavier Frapaise

|Jun 27, 2018
The End of Phase 3 Clinical Trials in Biosimilars Development?

Francois-Xavier Frapaise

Pageof 1

Frequent Collaborators